CRYM Stock Analysis
CR
Uncovered
Cryomass Technologies Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
CryoMass Technologies, Inc. engages in the operation of medical marijuana dispensaries and related businesses. The company is headquartered in Denver, Colorado. The company went IPO on 2013-11-26. The Company’s offerings include refinement systems and monitoring and control systems. Its refinement system uses technology to freeze the whole plant and separates the trichomes, which include tetrahydrocannabinol (THC), cannabinoids (CBD) and terpenes, from the biomass. CryoCann 500 CF is the Company’s refinement system. Its monitoring and control systems include flow control systems, security systems, data logger systems, remote monitoring and control systems of variables, and security systems for atmosphere composition control. Its flow control system includes automatic proportional valves and centrifugal pumps. The CryoMass Refinement System uses technology to freeze the whole plant and fully separates the trichomes, including terminal handling charges (THC), cannabidiol (CBD) and terpenes, from the biomass.